Clinical Trials for Multidrug Resistant Tuberculosis

Find clinical trials for multidrug resistant tuberculosis. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

NCT ID: NCT05081401

The INSPIRE-TB trial is studying a new treatment approach for patients with multidrug-resistant tuberculosis (TB) that is resistant to a medication called rifampicin. The goal of this trial is to s...

Recruiting

Phase: PHASE3 Type: interventional Locations: Shanghai, Shanghai, China, Zunyi, Guizhou, China +3 more

Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)

NCT ID: NCT05534750

The TEDITUB clinical trial is studying two medications, tedizolid and linezolid, to see how effective they are in killing the bacteria that cause tuberculosis (TB), particularly in cases where the ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Paris, , France

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions